{
    "2019-08-02": [
        [
            {
                "time": "2023-10-15",
                "original_text": "Pharma Stock Roundup: PFE, MRK, LLY Q2 Earnings, Upjohn-MYL Merger",
                "features": {
                    "keywords": [
                        "PFE",
                        "MRK",
                        "LLY",
                        "Q2 Earnings",
                        "Upjohn-MYL Merger"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2023-10-15",
                "original_text": "Biogen on the brink: One of the state's largest drugmakers faces a crisis",
                "features": {
                    "keywords": [
                        "Biogen",
                        "crisis"
                    ],
                    "sentiment_score": -0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            }
        ]
    ]
}